TrialScientific reports2020

Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy.

Itziar Irurzun-Arana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.